Extracorporeal membrane oxygenation: a ten-year experience.
Am J Surg
; 180(2): 144-54, 2000 Aug.
Article
en En
| MEDLINE
| ID: mdl-11044532
ABSTRACT
BACKGROUND:
Extracorporeal membrane oxygenation (ECMO) is a supportive therapy used for severe acute respiratory distress syndrome (ARDS). We present outcome, clinical parameters, and complications in a cohort of 245 ARDS patients of whom 62 were treated with ECMO.METHODS:
Data of all ARDS patients were prospectively collected between 1991 and 1999. Outcome and clinical parameters of patients treated with and without ECMO were evaluated.RESULTS:
One hundred thirty-eight patients were referred from other hospitals, 107 were primarily located in our hospital. About one fourth of these patients were treated with ECMO. The survival rate was 55% in ECMO patients and 61% in non-ECMO patients.CONCLUSIONS:
ECMO is a therapeutic option for patients with severe ARDS, likely to increase survival. However, a randomized controlled study proving its benefit is still awaited. Until the development of a causal or otherwise superior therapy ECMO should be used in selected patients.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Síndrome de Dificultad Respiratoria
/
Oxigenación por Membrana Extracorpórea
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
Am J Surg
Año:
2000
Tipo del documento:
Article